Rebyota (fecal microbiota, live-jslm) / Ferring 
Welcome,         Profile    Billing    Logout  
 4 Diseases   3 Trials   3 Trials   153 News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rebyota (fecal microbiota, live-jslm) / Ferring
CD3-OLS, NCT03931941: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH )

Completed
3
793
Canada, US
RBX2660, Microbiota suspension
Rebiotix Inc.
Clostridium Difficile Infection, Infection, Communicable Diseases
07/23
07/23
CDI-SCOPE, NCT05831189: A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Active, not recruiting
3
41
US
RBX2660, REBYOTA®
Ferring Pharmaceuticals
Clostridium Difficile Infection Recurrence
01/25
01/25
PediCRaFT, NCT03378167 / 2016-005207-30: Pediatric Crohn's Disease Fecal Transplant Trial

Completed
1
17
Canada
MICROBIOTA, RBX2660, RBX7455, Fecal microbiota transplant, PLACEBO
McMaster Children's Hospital, St. Justine's Hospital
Crohn Disease, Pediatric Crohns Disease, Inflammatory Bowel Diseases, Colitis
09/23
09/23
ROAR, NCT05835219: REBYOTA™ Prospective Registry

Recruiting
N/A
200
US
REBYOTA™
Ferring Pharmaceuticals
Recurrence of Clostridium Difficile Infection
02/26
04/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rebyota (fecal microbiota, live-jslm) / Ferring
CD3-OLS, NCT03931941: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH )

Completed
3
793
Canada, US
RBX2660, Microbiota suspension
Rebiotix Inc.
Clostridium Difficile Infection, Infection, Communicable Diseases
07/23
07/23
CDI-SCOPE, NCT05831189: A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Active, not recruiting
3
41
US
RBX2660, REBYOTA®
Ferring Pharmaceuticals
Clostridium Difficile Infection Recurrence
01/25
01/25
PediCRaFT, NCT03378167 / 2016-005207-30: Pediatric Crohn's Disease Fecal Transplant Trial

Completed
1
17
Canada
MICROBIOTA, RBX2660, RBX7455, Fecal microbiota transplant, PLACEBO
McMaster Children's Hospital, St. Justine's Hospital
Crohn Disease, Pediatric Crohns Disease, Inflammatory Bowel Diseases, Colitis
09/23
09/23
ROAR, NCT05835219: REBYOTA™ Prospective Registry

Recruiting
N/A
200
US
REBYOTA™
Ferring Pharmaceuticals
Recurrence of Clostridium Difficile Infection
02/26
04/26

Download Options